Aqtis Medical from michael richardson's blog

Our unique proprietary technology platform is the basis of our bioresorbable medical polymer and gel formulations, including the Ellansé dermal filler Family. AQTIS Medical, a Sinclair company, specializes in the research, development, manufacturing, and commercialization of innovative injectable medical devices. AQTIS Medical is a world-leading medical device group that creates and manufactures innovative injectable medical devices for the medical aesthetic market. Our core therapy areas are Dermal Fillers, Mesotherapy, and Micro shaping.

https://aestheticdermalfillerssupply.com/product-category/aqtis-medical/

AQTIS Medical is a medical technology company focused on developing and innovating injectable products to improve patients’ quality of life. We’re committed to offering safe, sustainable solutions, using the latest technology and highest-quality materials. We have a team of highly skilled technicians and technical support staff, with extensive experience in the design, development, and validation of medical devices, including automated production equipment. Our manufacturing and test processes are robust, validated, and comply with European and US FDA regulators to produce high-quality products.

AQTIS Medical provides the aesthetics industry with superior product quality, enabling unique, safe and effective products. AQTIS Medical focuses on delivering non-allergenic products that can be customized to meet specific aesthetic and novel engineering challenges. Our main goal is to provide consumers and medical professionals with access to the safest, longest-lasting and most effective medical products by using cutting edge technology. Our products are developed as a result of extensive research and partnerships with leading universities and institutions in the field of bioresorbable implants. Doctor’s and patients are seeking alternatives to more invasive, expensive, non-biodegradable procedures. We provide a natural solution for aesthetic applications.


Previous post     
     Next post
     Blog home

The Wall

No comments
You need to sign in to comment

Post

By michael richardson
Added Feb 15 '22

Tags

Rate

Your rate:
Total: (0 rates)

Archives